iShares Trust - iShares Biotechnology ETF reported earnings results for the half year ended September 30, 2023. For the half year, the company reported revenue was USD 25.78 million. Net loss was USD 403.36 million.
iShares Trust - iShares Nasdaq Biotechnology ETF
Equities
IBB
US4642875565
Investment Trusts
1st Jan change | Capi. | |
---|---|---|
+3.27% | 14.32B | |
+3.12% | 6.21B | |
+12.72% | 4.4B | |
+10.97% | 4.36B | |
-7.52% | 4B | |
+3.61% | 3.51B | |
+8.55% | 3.21B | |
+7.91% | 3.06B | |
-1.91% | 2.77B |